Hadean closes €100M life sciences fund

Hadean Ventures said it closed life sciences fund Hadean Capital I at €100 million ($117.9 million). Hadean will invest €6-€8 million ($7.1-$9.4 million) in about 10-12 European start-ups, with an emphasis on the Nordic region, and plans to make its first investment in 1Q18.

Investors in the fund included Argentum, Saminvest, Gjensidigestiftelsen, OPF and Varner. Argentum said in September it invested NOK150 million ($17.9 million)...